Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N1PW
|
||||
Former ID |
DNC014612
|
||||
Drug Name |
4-Indol-1-ylmethyl-benzamidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H15N3
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C=CN2CC3=CC=C(C=C3)C(=N)N
|
||||
InChI |
1S/C16H15N3/c17-16(18)14-7-5-12(6-8-14)11-19-10-9-13-3-1-2-4-15(13)19/h1-10H,11H2,(H3,17,18)
|
||||
InChIKey |
VKEKMIKRPJWXHO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Trypsin | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Pancreatic secretion | |||||
Protein digestion and absorption | |||||
Influenza A | |||||
Reactome | Activation of Matrix Metalloproteinases | ||||
Cobalamin (Cbl, vitamin B12) transport and metabolism | |||||
WikiPathways | Activation of Matrix Metalloproteinases | ||||
References | |||||
REF 1 | J Med Chem. 1983 Feb;26(2):294-8.Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.